INS and Hypoglycemia: The results from the SOLVETM cohort in Turkey are consistent with previously reported randomised clinical trials and non-investigational study data of insulin detemir with regard to effective glycaemic control, low incidence of hypoglycaemia and a weight-sparing effect.